Treatment of patients with AMI during hospital stay by age groups
| Age groups | P value | Total sample (n=5530) | ||
| 65–74 (n=3709) | 75–84 (n=1821) | |||
| Drug treatment of patients with AMI | ||||
| Antiplatelets | 3661 (98.7%) | 1806 (99.1%) | 0.158 | 5467 (98.8%) |
| Ca-antagonists | 1343 (36.2%) | 748 (41.1%) | <0.001 | 2091 (37.8%) |
| ACE inhibitors | 3007 (81.1%) | 1337 (73.4%) | <0.001 | 4344 (78.5%) |
| Beta-blockers | 3492 (94.1%) | 1683 (92.4%) | 0.016 | 5175 (93.6%) |
| Nitrates | 2948 (79.5%) | 1237 (67.9%) | <0.001 | 4185 (75.7%) |
| Angiotensin II antagonists | 404 (10.9%) | 327 (17.9%) | <0.001 | 731 (13.2%) |
| Other antihypertensives | 635 (17.1%) | 395 (21.7%) | <0.001 | 1030 (18.6%) |
| Statins | 3284 (88.5%) | 1614 (88.6%) | 0.956 | 4898 (88.6%) |
| Insulin | 1250 (33.7%) | 610 (33.5%) | 0.904 | 1860 (33.6%) |
| Recanalisation therapy of patients with AMI | ||||
| At least one recanalisation therapy | 2941 (79.3%) | 1271 (69.8%) | <0.001 | 4212 (76.2%) |
| PCI | 2294 (61.8%) | 1064 (58.4%) | 0.015 | 3358 (60.7%) |
| Bypass | 672 (18.1%) | 236 (13.0%) | <0.001 | 908 (16.4%) |
| Thrombolytic therapy | 160 (4.3%) | 8 (0.4%) | <0.001 | 168 (3.0%) |
AMI, acute myocardial infarction; PCI, percutaneous coronary intervention.